Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
- Author
- A DEMOLS, Marc Peeters (UGent) , M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ and JL VAN LAETHEM
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-332016
- MLA
- DEMOLS, A., et al. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study.” BRITISH JOURNAL OF CANCER, vol. 94, no. 4, NATURE PUBLISHING GROUP, 2006, pp. 481–85.
- APA
- DEMOLS, A., Peeters, M., POLUS, M., MARECHAL, R., GAY, F., MONSAERT, E., … VAN LAETHEM, J. (2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER, 94(4), 481–485.
- Chicago author-date
- DEMOLS, A, Marc Peeters, M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ, and JL VAN LAETHEM. 2006. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study.” BRITISH JOURNAL OF CANCER 94 (4): 481–85.
- Chicago author-date (all authors)
- DEMOLS, A, Marc Peeters, M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ, and JL VAN LAETHEM. 2006. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study.” BRITISH JOURNAL OF CANCER 94 (4): 481–485.
- Vancouver
- 1.DEMOLS A, Peeters M, POLUS M, MARECHAL R, GAY F, MONSAERT E, et al. Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER. 2006;94(4):481–5.
- IEEE
- [1]A. DEMOLS et al., “Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study,” BRITISH JOURNAL OF CANCER, vol. 94, no. 4, pp. 481–485, 2006.
@article{332016,
author = {{DEMOLS, A and Peeters, Marc and POLUS, M and MARECHAL, R and GAY, F and MONSAERT, ELS and HENDLISZ, A and VAN LAETHEM, JL}},
issn = {{0007-0920}},
journal = {{BRITISH JOURNAL OF CANCER}},
language = {{eng}},
number = {{4}},
pages = {{481--485}},
publisher = {{NATURE PUBLISHING GROUP}},
title = {{Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study}},
volume = {{94}},
year = {{2006}},
}